263
Participants
Start Date
August 31, 2007
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Tesamorelin
Placebo for Tesamorelin
C. H. U. Sart-Tilman, Liège
AIDS Community Research Initiative of America, New York
Hosp.C.U.de Santiago, Santiago de Compostela
Hosp. Ramon y Cajal, Madrid
Hosp. Clinico San Carlos, Madrid
AIDS Research Consortium Atlanta (ARCA), Atlanta
Office of Dr. Gary Richmond, Fort Lauderdale
Infectious Disease Research Institute Inc., Tampa
Hendry/Glades County Health Departments, LaBelle
Hotel Dieu, Nantes
University Hospitals of Cleveland, Cleveland
Indiana University Department of Medicine, Indianapolis
Northern Healthcare, Chicago
Northstar Medical, Chicago
Hôpital Hotel Dieu Lyon, Lyon
Hopital Europeen Georges Pompidou, Paris
University of Texas Southwestern Medical Center at Dallas, Dallas
Hopital Necker, Paris
Central Texas Clinical Research, Austin
Body Positive Inc., Phoenix
UCLA School of Medicine, Los Angeles
AIDS Research Alliance, West Hollywood
Somero, Michael, Indio
Office of Dr. Michael Somero, Palm Springs
University of California, San Francisco
Kaiser Permanente, San Francisco
UCSF/VA Medical Center, San Francisco
Swedish Medical Center, Seattle
University of Alabama at Birmingham, Birmingham
Denver Public Health Department, Denver
Tufts University School of Medicine, Boston
Massachusetts General Hospital, Boston
The Research Institute, Springfield
ID Associates, Hillsborough
University of North Carolina at Chapel Hill, Chapel Hill
St-Paul's Hospital, Vancouver
McMaster University Health Sciences Centre, Hamilton
Sunnybrook Health Sciences Centre, Toronto
Toronto General Hospital, Toronto
Centre Hospitalier Universitaire de Santé de l'Estrie, Fleurimont
Montreal General Hospital, Montreal
Groupe de Recherche en Rhumatologie et maladies osseuses, Ste-Foy
BSUH NHS Trust, Brighton
St Georges Hospital, London
Royal Free Hospital, London
Chelsea and Westminster Hospital, London
St Mary's NHS Trust, London
Lead Sponsor
Theratechnologies
INDUSTRY